Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Leukemia 42Lymphoma 33Melanoma 32Breast Neoplasms 31Leukemia, Myeloid, Acute 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Leukemia, Lymphocytic, Chronic, B-Cell 23Lymphoma, Non-Hodgkin 22Multiple Myeloma 21Lymphoma, Follicular 21Myelodysplastic Syndromes 19Prostatic Neoplasms 18Neuroblastoma 18Lymphoma, Mantle-Cell 17Lymphoma, Large B-Cell, Diffuse 17Leukemia, Myeloid, Chronic-Phase 16Hodgkin Disease 15Neoplasms, Plasma Cell 14Lymphoma, Large-Cell, Immunoblastic 14Ovarian Neoplasms 13Lung Neoplasms 13Congenital Abnormalities 13Lymphoma, B-Cell, Marginal Zone 12Leukemia, Myeloid, Accelerated Phase 12Carcinoma, Non-Small-Cell Lung 12Burkitt Lymphoma 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Glioblastoma 11Carcinoma, Ovarian Epithelial 11Colorectal Neoplasms 10

Interventions

Cisplatin 12Radiotherapy 10Cetuximab 9Fluorouracil 6Drug Therapy 5Docetaxel 5pembrolizumab 3Radiotherapy, Intensity-Modulated 3Radiation 3Laser Therapy 3Hydroxyurea 3sargramostim 2Surveys and Questionnaires 2Resistance Training 2Psychiatric Rehabilitation 2Nutritional Status 2Nicotine 2Counseling 2Celecoxib 2Carboplatin 2Bupropion 2Bronchoscopy 2sodium thiosulfate 1motexafin gadolinium 1gossypol acetic acid 1durvalumab 1adavosertib 1Zinc Oxide 1Varenicline 1Transcutaneous Electric Nerve Stimulation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Laryngeal Neoplasms × sargramostim × Clear all
NCT00008398 2013-11-19

Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Radiation Injuries

NCT00004256 2013-11-06

Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Head & Neck

Head and Neck Neoplasms, Laryngeal Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡